ATE453725T1 - Polymorphismen des humanen cyp2b6 gens und deren verwendung in diagnostischen und therapeutischen anwendungen - Google Patents

Polymorphismen des humanen cyp2b6 gens und deren verwendung in diagnostischen und therapeutischen anwendungen

Info

Publication number
ATE453725T1
ATE453725T1 AT01913809T AT01913809T ATE453725T1 AT E453725 T1 ATE453725 T1 AT E453725T1 AT 01913809 T AT01913809 T AT 01913809T AT 01913809 T AT01913809 T AT 01913809T AT E453725 T1 ATE453725 T1 AT E453725T1
Authority
AT
Austria
Prior art keywords
cyp2b6
well
polynucleotides
diagnosing
vectors
Prior art date
Application number
AT01913809T
Other languages
English (en)
Inventor
Ulrich Zanger
Thomas Lang
Original Assignee
Epidauros Biotechnologie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epidauros Biotechnologie Ag filed Critical Epidauros Biotechnologie Ag
Application granted granted Critical
Publication of ATE453725T1 publication Critical patent/ATE453725T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • C12N9/0038—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6) with a heme protein as acceptor (1.6.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
AT01913809T 2000-02-09 2001-02-09 Polymorphismen des humanen cyp2b6 gens und deren verwendung in diagnostischen und therapeutischen anwendungen ATE453725T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00102701 2000-02-09
PCT/EP2001/001456 WO2001059152A2 (en) 2000-02-09 2001-02-09 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications

Publications (1)

Publication Number Publication Date
ATE453725T1 true ATE453725T1 (de) 2010-01-15

Family

ID=8167810

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01913809T ATE453725T1 (de) 2000-02-09 2001-02-09 Polymorphismen des humanen cyp2b6 gens und deren verwendung in diagnostischen und therapeutischen anwendungen

Country Status (9)

Country Link
US (2) US20040224313A1 (de)
EP (1) EP1272663B1 (de)
AT (1) ATE453725T1 (de)
AU (1) AU3925701A (de)
DE (1) DE60140934D1 (de)
DK (1) DK1272663T3 (de)
ES (1) ES2338523T3 (de)
PT (1) PT1272663E (de)
WO (1) WO2001059152A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2660156T3 (es) * 2011-05-05 2018-03-21 Institut National De La Santé Et De La Recherche Médicale (Inserm) Proteínas 2B6 mutantes de citocromo P450 y usos de las mismas
CN115976190A (zh) * 2022-11-15 2023-04-18 苏州吉赛基因测序科技有限公司 剖宫产患者术后镇痛用药相关基因分型检测的产品及用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103314D0 (en) * 1991-02-16 1991-04-03 Imp Cancer Res Tech Assay systems
CA2128399A1 (en) * 1993-07-20 1995-01-21 Koji Hayashi Method for safety evaluation of chemical compound using recombinant yeast expressing human cytochrome p450
US5688773A (en) * 1994-08-17 1997-11-18 The General Hospital Corporation Method of selectively destroying neoplastic cells
US6207648B1 (en) * 1997-07-24 2001-03-27 Trustees Of Boston University Methods of using cytochrome P450 reductase for the enhancement of P450-based anti-cancer gene therapy
CN1357048A (zh) * 1998-03-06 2002-07-03 牛津生物医学（英国）有限公司 增强前体药物活化

Also Published As

Publication number Publication date
WO2001059152A2 (en) 2001-08-16
EP1272663B1 (de) 2009-12-30
PT1272663E (pt) 2010-03-01
US20090311696A1 (en) 2009-12-17
WO2001059152A9 (en) 2002-08-08
US20040224313A1 (en) 2004-11-11
AU3925701A (en) 2001-08-20
DK1272663T3 (da) 2010-04-26
EP1272663A2 (de) 2003-01-08
DE60140934D1 (de) 2010-02-11
ES2338523T3 (es) 2010-05-10
WO2001059152A3 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
Marek et al. Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells
Yin et al. The gene network underlying hypodontia
Jia et al. Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin–proteasomal and autophagy systems
Haberland et al. Genetic dissection of histone deacetylase requirement in tumor cells
Hida et al. Elucidation of melanogenesis cascade for identifying pathophysiology and therapeutic approach of pigmentary disorders and melanoma
Kober et al. Expression of mitochondrial dysfunction-related genes and pathways in paclitaxel-induced peripheral neuropathy in breast cancer survivors
Shin et al. Molecular and cellular changes in the lumbar spinal cord following thoracic injury: regulation by treadmill locomotor training
HUP0301246A2 (hu) Humán véralvadási faktor VII változatai
EE200200049A (et) Polümorfismid inimese MDR-1 geenis ning nende kasutamine diagnostikas ja terapeutilistes rakendustes
CN107849611A (zh) 与lsd1抑制剂相关的生物标志物及其用途
ATE365798T1 (de) Mittel und verfahren zur diagnose und behandlung affektiver störungen
WO2001020025A3 (en) Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications
Visconti et al. Epigenetics of myotonic dystrophies: a minireview
ATE513929T1 (de) Gene mit einfluss auf die menschliche gedächtnisleistung
ATE440967T1 (de) Auswahl von tieren für gewünschte genotypische und potentielle phänotypische eigenschaften auf der basis eines einzelnen nukleotidpolymorphismus (snp) im intron 3 des igf2-gens
Møller Johansen et al. Time course of DNA methylation in pain conditions: From experimental models to humans
Pang et al. High-throughput sequencing offers new insights into 5-hydroxymethylcytosine
ATE424469T1 (de) Für prkcb1 kodierendes humanes autismus- suszeptibilitätsgen und dessen verwendung
DE602004021186D1 (de) Menschliches autismus-suszeptibilitätsgen und verwendungen davon
ATE453725T1 (de) Polymorphismen des humanen cyp2b6 gens und deren verwendung in diagnostischen und therapeutischen anwendungen
Lorsch et al. Zfp189 mediates stress resilience through a CREB-regulated transcriptional network in prefrontal cortex
Alba-Pavón et al. Splicing-disrupting mutations in inherited predisposition to solid pediatric cancer
DE50312502D1 (de) Screeningverfahren zum identifizieren protektiver substanzen für die behandlung neurodegenerativer und/oder ischämischer erkrankungen
Machado Xavier et al. Essential contributions of enhancer genomic regulatory elements to microglial cell identity and functions
WO2004090113A3 (en) L53, a lung cancer associated antigen and uses thereof

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 1272663

Country of ref document: EP